Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

Sponsor
Cell Genesys (Industry)
Overall Status
Terminated
CT.gov ID
NCT00133224
Collaborator
(none)
408
115
2
47
3.5
0.1

Study Details

Study Description

Brief Summary

The primary objective of this study is to compare the duration of survival between patients receiving docetaxel in combination with the GVAX® vaccine for prostate cancer versus patients receiving docetaxel and prednisone treatment in patients with prostate cancer who no longer respond to hormone therapy, who have documented metastases with pain. Patients may have had up to one prior non-taxane chemotherapy treatment.

Condition or Disease Intervention/Treatment Phase
  • Biological: Immunotherapy allogeneic GM-CSF secreting cellular vaccine
  • Drug: Chemotherapy (docetaxel and prednisone)
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
408 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Phase III Randomized, Open-Label Study of Docetaxel in Combination With CG1940 and CG8711 Versus Docetaxel and Prednisone in Taxane-Naïve Patients With Metastatic Hormone-Refractory Prostate Cancer With Pain
Study Start Date :
Jul 1, 2005
Actual Primary Completion Date :
Aug 1, 2008
Anticipated Study Completion Date :
Jun 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Biological: Immunotherapy allogeneic GM-CSF secreting cellular vaccine
Immunotherapy allogeneic GM-CSF secreting cellular vaccine

Other: 2

Drug: Chemotherapy (docetaxel and prednisone)
Chemotherapy (docetaxel and prednisone)

Outcome Measures

Primary Outcome Measures

  1. Survival [0]

Secondary Outcome Measures

  1. Time to disease progression. Time to pain progression. [0]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Confirmed diagnosis of or clinical history consistent with adenocarcinoma of the prostate

  • Metastatic prostate cancer deemed to be unresponsive or refractory to hormone therapy

  • Detectable metastases

  • ECOG performance status ≤2 (Performance status of 3 if due to bone pain)

  • Any Gleason score

  • Only one prior treatment with systemic chemotherapy

  • No prior treatment with gene therapy

  • No prior immunotherapy for prostate cancer

  • Taxane naïve

  • Experiencing cancer-related pain

Contacts and Locations

Locations

Site City State Country Postal Code
1 Alaska Clinical Research Center Anchorage Alaska United States 99508
2 St. Edward Mercy Medical Center Fort Smith Arkansas United States 72917
3 Loma Linda University Loma Linda California United States 92354
4 Onocology Care Medical Associates Los Angeles California United States 90057
5 Desert Hematology Oncology Medical Group Rancho Mirage California United States 92270
6 San Bernardino Urology Associates San Bernardino California United States 92404
7 Kaiser Permanente Medical Group Dept. of Oncology Research San Diego California United States 92120
8 Sharp Healthcare San Diego California United States 92123
9 California Pacific Medical Center San Francisco California United States 94115
10 UCSF Mt. Zion Cancer Center San Francisco California United States 94115
11 Cancer Research & Prevention Center Soquel California United States 95073
12 Cancer Center and Department of Medicine Aurora Colorado United States 80010
13 Mayo Clinic - Jacksonville Jacksonville Florida United States 32224
14 Jupiter Hematology & Oncology Associates Jupiter Florida United States 33458
15 Lakeland Regional Cancer Center Lakeland Florida United States 33804
16 Hematology Oncology Associates of the Treasure Coast Port St. Lucie Florida United States 34952
17 Atlanta VA Medical Center Atlanta Georgia United States 30033
18 Peachtree Hematology & Oncology Consultants, PC Atlanta Georgia United States 30309
19 Emory Winship Cancer Institute Atlanta Georgia United States 30322
20 Medical & Surgical Specialists Galesburg Illinois United States 61401
21 James Graham Brown Cancer Center Louisville Kentucky United States 40202
22 Frederick Memorial Hospital Regional Cancer Therapy Center Frederick Maryland United States 21701
23 General Clinical Research Center University of Michigan Ann Arbor Michigan United States 48109
24 Billings Clinic Billings Montana United States 59101
25 Hematology & Oncology Consultants P.C. Omaha Nebraska United States 68122
26 Nevada Cancer Institute Las Vegas Nevada United States 89135
27 Hackensack University Medical Center Hackensack New Jersey United States 07601
28 New Mexico Oncology Albuquerque New Mexico United States 87109
29 North Shore Hematology Oncology Associates P.C. East Setauket New York United States 11733
30 NYU Clinical Cancer Center New York New York United States 10016
31 Presbyterian Hospital Center for Cancer Research Charlotte North Carolina United States 28204
32 Gabrail Cancer Center Canton Ohio United States 44718
33 Providence Portland Medical Center Portland Oregon United States 97213
34 Kaiser Permanente Oncology/Hematology Portland Oregon United States 97227
35 Cancer Centers of the Carolinas Greenville South Carolina United States 29605
36 The West Clinic Memphis Tennessee United States 38120
37 Center for Oncology Research & Treatment, PA Dallas Texas United States 75230
38 Dallas Oncology Consultants Dallas Texas United States 75237
39 Mary Crowley Medical Research Center Dallas Texas United States 75246
40 Mobley Research Center Houston Texas United States 77024
41 Northwest Cancer Center Houston Texas United States 77042
42 Urology San Antonio Research, PA San Antonio Texas United States 78229
43 Seattle Cancer Care Alliance, Univ. of Washington Seattle Washington United States 98109
44 Ziekenhuis Netwerk Antwerpen - AZ Middelheim Antwerpen Belgium B-2020
45 V.Z.W. Imelda Ziekenhuis Bonheiden Belgium B-2820
46 AZ Groeninge Kortrijk Belgium B-8500
47 CHU de Liège - Hôpital du Sart Tilman Liège Belgium B-4000
48 Heilig-Hartziekenhuis Campus Wilgenstraat Roeselare Belgium B- 8800
49 Regionaal Ziekenhuis Sint Trudo Sint Truiden Belgium B-3800
50 Centre Hospitalier de L'Universite de Montreal Montreal Quebec Canada H2L 4M1
51 Centre Hospitalier Universite de Sherbrooke Sherbrooke Quebec Canada J1H 5N4
52 Centre Regional de lutte contre le cancer Paul Papin Angers France 49033
53 Centre Francois Baclesse Caen France 14076
54 Institut Jean Godinot, Oncologie Medicale Cedex France 51056
55 Centre Jean Perrin Centre Régional de lutte contre le cancer d'Auvergne Clermont-Ferrand France 63011
56 Centre Rene Gauducheau - Site Hospitalier Nord Nantes France 44805
57 Centre Antoine Lacassagne - Centre Regional de lutte contre le cancer Nice France 06189
58 CHU Saint Louis Paris France 75010
59 Hopital Saint Joseph Site Saint Michel Paris France 75015
60 Hopital Cochin Paris France 75674
61 CHU Poitiers Poitiers France 86021
62 Centre Hospitalier Rene Dubos Pontoise France 95303
63 Clinique Armoricaine de Radiology Saint Brieuc France 22015
64 Hopital Civil Strasbourg France 67091
65 CHU Bretonneau Tours France 37044
66 Centre Alexis Vautrin Vandoeuvre les Nancy France 54500
67 Universitatsklinikum Aachen Aachen Germany 52074
68 Charite Campus Mitte Berlin Germany 10117
69 Krankenhaus Am Urban Berlin Germany 10967
70 Universitatsklinikum Carl Gustav Carus An Der Dresden Germany 01307
71 Klinikum der Johann Wolfgang Goethe-Universitat Frankfurt am Main Germany 60590
72 Urologische Klinik und Poliklinik der Johannes Gutenberg Universitat Mainz Mainz Germany 55131
73 Klinikum Mannheim Mannheim Germany 68135
74 Urologische Klinik und Poliklinik Munchen Germany 81675
75 Istituto Nazionale dei Tumori Milano Italy 20133
76 Fondazione IRCCS Ospedale Maggiore Policlinico Milan Italy 20122
77 Fondazione San Raffaele del Monte Tabor Milan Italy 20132
78 Istituto Europeo di Oncologia Milan Italy 20141
79 Azienda Ospedaliero Universitaria di Modena Modena Italy 41100
80 Azienda Ospedaliera Maggiore della Carita Novarra Italy 28100
81 Azienda Ospedaliera di Parma Parma Italy 43100
82 Azienda Ospedaliero Universitaria (A.O.U.) Pisana-Ospedale S. Chiara Pisa Italy 56126
83 Azienda Ospedaliera San Camillo Forlanini Roma Italy 00152
84 Presidio Ospedaliero di Sassari-Ospedale SS. Anunziata Sassari Italy 07100
85 A.S.O. San Giovanni Battista di Torino Turin Italy 10126
86 VU Medisch Centrum Amsterdam Netherlands 1081 HV
87 Academisch Centrum Amsterdam Netherlands 1105 AZ
88 Universitair Medisch Centrum Groningen Groningen Netherlands 9713 GZ
89 Samodzielny Publiczny Zaklad Opieki Zdrowotnej Bialystok Poland 15-950
90 Samodzielny Publiczny Zaklad Opieki Zdrowotnej Bytom Poland 41-902
91 Katedra i Klinika Onkologii i Radioterapli Gdansk Poland 80-952
92 Samodzielny Publiczny Zaklad Opieki Zdrowotnej Katowice Poland 40-073
93 Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie Oddzial w Krakowie Krakow Poland 31-115
94 Wojewodzki Szpital Specjalistyczny im. M. Kopernika Lodz Poland 93-509
95 Samodzielny Publiczny Szpital Kliniczny nr 1 Przemienienia Panskiego AM w Poznaniu Poznan Poland 61-848
96 Wojewodzki Szpital Specjalistyczny w Siedlcach Siedlce Poland 08-110
97 Wojewodzki Szpital Specjalistyczny Oddzial Urologii Slupsk Poland 76-200
98 Szpital Kliniczny Dzieciatka Jezus - Centrum Leczenia Obrazen Warszawa Poland 02-005
99 Centrum Onkologii Instytut im. Marii Sklodowskiej- Curie Warszawa Poland 02-781
100 Universitetssjukhuset i Lund Lund Sweden SE-22185
101 University Hospital MAS (UMAS) Malmo Sweden SE-205 02
102 Akademiska Sjukhuset i Uppsala Uppsala Sweden SE-75185
103 Addenbrookes Hospital Cambridge United Kingdom CB2 2QQ
104 Royal Surrey County Hospital Guildford United Kingdom GU2 7XX
105 St. James University Hospital Leeds United Kingdom LS9 7TF
106 Lincoln County Hospital Lincoln United Kingdom LN2 4AX
107 Royal Marsden Hospital London United Kingdom SW3 6JJ
108 Department of Oncology Hammersmith Hospital London United Kingdom W12 0NN
109 Christie Hospital Manchester Manchester United Kingdom M20 4BX
110 Mount Vernon Hospital Middlesex United Kingdom HA6 2RN
111 Nottingham City Hospital Nottingham United Kingdom NG5 1PB
112 Rosemere Cancer Centre, Royal Preston Hospital Preston United Kingdom PR2 9HT
113 Scunthorpe General Hospital, Dept of Oncology Scunthorpe United Kingdom DN15 7BH
114 Royal Marsden Academic Urology Unit Sutton United Kingdom SM2 5PT
115 Clatterbridge Centre For Oncology Wirral United Kingdom CH63 4JY

Sponsors and Collaborators

  • Cell Genesys

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00133224
Other Study ID Numbers:
  • G-0034
  • VITAL-2
First Posted:
Aug 23, 2005
Last Update Posted:
Sep 23, 2008
Last Verified:
Sep 1, 2008

Study Results

No Results Posted as of Sep 23, 2008